Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort

Figure 1 Inflammatory bowel disease unclassified incidence rates (1977-2018). A: Grouped annual inflammatory bowel disease unclassified (IBD-U) incidence rates (1977-2018); B: Age-specific mean IBD-U incidence rates (1977-2018). IBD-U: Inflammatory bowel disease unclassified.

Figure 2 Cumulative probability of medication exposure. A: Cumulative exposure to inflammatory bowel disease (IBD) specific medications stratified by the time of diagnosis; B: Cumulative probability of biological therapy initiation in incident unclassified IBD patients - sub-analysis (2000-2018). IBD-U: Inflammatory bowel disease unclassified.

Figure 3 Cumulative probability of disease extent progression. A: Cumulative probability of colonic disease extent progression in incident inflammatory bowel disease unclassified (IBD-U) patients (1977-2018); B: Cumulative probability of developing terminal ileitis in incident IBD-U patients (1977-2018). IBD-U: Inflammatory bowel disease unclassified.

Figure 4 Cumulative probability of first surgical resection in incident inflammatory bowel disease unclassified patients (1977-2018). IBD-U: Inflammatory bowel disease unclassified.